Foundations and Adult Health Nursing Test Bank Related

Review Foundations and Adult Health Nursing Test Bank related questions and content

A patient with chronic kidney disease presents with progressively worsening anemia and elevated serum phosphate levels. Which medication is commonly prescribed to reduce serum phosphate levels in patients with chronic kidney disease?

  • A. Epoetin alfa
  • B. Cinacalcet
  • C. Sevelamer
  • D. Allopurinol
Correct Answer: C

Rationale: Sevelamer is a medication commonly prescribed to reduce serum phosphate levels in patients with chronic kidney disease. Sevelamer is a phosphate binder that works by binding to dietary phosphate in the gut, preventing its absorption into the bloodstream. By reducing serum phosphate levels, sevelamer helps manage complications associated with hyperphosphatemia in chronic kidney disease patients, such as mineral and bone disorders. Other medications like epoetin alfa are used to treat anemia commonly seen in chronic kidney disease patients, while cinacalcet is used to manage secondary hyperparathyroidism. Allopurinol, on the other hand, is used to treat gout by reducing uric acid levels and is not indicated for reducing serum phosphate levels in chronic kidney disease patients.